Amundi Neogenomics Inc Transaction History

Amundi

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $35,087 - $75,077	-3,860 Reduced 44.56%	4,802 $83,000
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $19,498 - $36,487	-3,023 Reduced 25.87%	8,662 $80,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $82,496 - $163,239	11,685 New	11,685 $97,000

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.